AN2 Therapeutics, Inc. (ANTX)

4.00 +0.20 (+5.26%) USD  |  NASDAQ  |  Apr 22, 16:00
4.00 0.00 (0.00%) After-Hours: 19:47
More

AN2 Therapeutics Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Relmada Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade